Indexed with PubMed and Science Citation Index (E) 
Users online: 5601 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (498 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded17    
    Comments [Add]    

Recommend this journal


 Table of Contents    
Year : 2019  |  Volume : 85  |  Issue : 4  |  Page : 412-413

Author's reply

Consultant Dermatologist, Dr. Dashore's DHL Clinic, Indore, MP, India

Date of Web Publication7-Jun-2019

Correspondence Address:
Dr. Shuken Dashore
Consultant Dermatologist, Dr. Dashore's DHL Clinic, Indore, MP
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijdvl.IJDVL_384_19

Rights and Permissions

How to cite this article:
Dashore S. Author's reply. Indian J Dermatol Venereol Leprol 2019;85:412-3

How to cite this URL:
Dashore S. Author's reply. Indian J Dermatol Venereol Leprol [serial online] 2019 [cited 2020 Nov 26];85:412-3. Available from:


I would like to thank you for your interest in our case of two rare variants of dermatofibrosarcoma protuberans. You have rightly pointed out that there is an increased prevalence of this condition in HIV seropositive cases.[1] However, case 1 described in the letter to the editor had persistent slowly progressive lesion since the past 25 years with no history suggestive of HIV seropositivity occurring before the appearance of lesion and progression of the same over the period of 25 years.[2] You have also rightly stated that the incidence of HIV seroprevalence in India is higher than global average.[3] However, the case in discussion hails from Madhya Pradesh which is a low prevalence state for HIV.[4] Prevalence of HIV seropositivity in blood donors in the state of Madhya Pradesh was found to be 0.10%, which is lower than the global average (0.2%).[4] In view of the above factors, HIV testing was not undertaken. We agree with the argument that HIV testing must be done in cases of atypical cases of dermatofibrosarcoma protuberans especially in areas of high prevalence of HIV.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Sapadin AN, Gelfand JM, Howe KL, Phelps RG, Grand D, Rudikoff D, et al. Dermatofibrosarcoma protuberans in two patients with acquired immunodeficiency syndrome. Cutis 2000;65:85-8.  Back to cited text no. 1
Jain S, Dashore S, Singhania B, Khopkar US, Darkase B. Dermatofibrosarcoma protuberans: Two rare variants. Indian J Dermatol Venereol Leprol 2019;85:204-8.  Back to cited text no. 2
[PUBMED]  [Full text]  
Paranjape RS, Challacombe SJ. HIV/AIDS in India: An overview of the Indian epidemic. Oral Dis 2016;22 Suppl 1:10-4.  Back to cited text no. 3
Yadav UC, Sharma D, Shrivatava M, Jain A. Prevalence of HIV among blood donors at Madhya Pradesh, a central state of India. IOSR J Dent Med Sci 2018;17:57-64.  Back to cited text no. 4


Print this article  Email this article


Online since 15th March '04
Published by Wolters Kluwer - Medknow